WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+9.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$11.8B
AUM Growth
+$1.41B
(+13%)
Cap. Flow
+$896M
Cap. Flow
% of AUM
7.57%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
744
New
202
Increased
220
Reduced
152
Closed
160
Top Buys
| 1 |
ASML
ASML
|
$125M |
| 2 |
Meta Platforms (Facebook)
META
|
$100M |
| 3 |
STMicroelectronics
STM
|
$92.5M |
| 4 |
MetLife
MET
|
$79.4M |
| 5 |
Gilead Sciences
GILD
|
$77.3M |
Top Sells
| 1 |
TE Connectivity
TEL
|
$161M |
| 2 |
Eli Lilly
LLY
|
$151M |
| 3 |
Marsh & McLennan
MMC
|
$123M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$86.7M |
| 5 |
Electronic Arts
EA
|
$78.6M |
Sector Composition
| 1 | Healthcare | 43.57% |
| 2 | Technology | 17.47% |
| 3 | Industrials | 8.1% |
| 4 | Energy | 6.42% |
| 5 | Financials | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Cisco
CSCO
$264B
| $15.1M | 0.13% |
282,978
-293,611
| -51% | -$15.6M |
|
227
General Mills
GIS
$27B
| $15M | 0.13% |
+203,541
| New | +$15M |
|
228
Ultragenyx Pharmaceutical
RARE
$3.07B
| $14.9M | 0.13% |
267,555
+765
| +0.3% | +$42.5K |
|
229
Meritage Homes
MTH
$5.89B
| $14.7M | 0.12% |
+143,276
| New | +$14.7M |
|
|
VRNA
230
Verona Pharma
VRNA
$9.2B
| $14.6M | 0.12% |
507,945
+6,747
| +1% | +$194K |
|
231
RenaissanceRe
RNR
$11.3B
| $14.6M | 0.12% |
53,505
-203,209
| -79% | -$55.4M |
|
232
Structure Therapeutics
GPCR
$1.27B
| $14.6M | 0.12% |
331,573
-5,828
| -2% | -$256K |
|
233
ARS Pharmaceuticals
SPRY
$995M
| $14.3M | 0.12% |
986,007
+704,863
| +251% | +$10.2M |
|
234
Alcoa
AA
$8.24B
| $14.2M | 0.12% |
+369,308
| New | +$14.2M |
|
235
W.W. Grainger
GWW
$47.5B
| $14.2M | 0.12% |
13,715
+4,168
| +44% | +$4.33M |
|
236
Canadian Pacific Kansas City
CP
$70.3B
| $14.2M | 0.12% |
165,649
+10,492
| +7% | +$897K |
|
237
International Flavors & Fragrances
IFF
$16.9B
| $14.1M | 0.12% |
134,444
-109,248
| -45% | -$11.5M |
|
238
Edgewise Therapeutics
EWTX
$1.64B
| $14.1M | 0.12% |
527,839
+106,235
| +25% | +$2.84M |
|
239
BioNTech
BNTX
$27B
| $14M | 0.12% |
117,785
+5,247
| +5% | +$623K |
|
|
CHX
240
DELISTED
ChampionX
CHX
| $13.9M | 0.12% |
460,000
| – | – |
|
241
Albertsons Companies
ACI
$10.7B
| $13.7M | 0.12% |
739,999
-260,000
| -26% | -$4.8M |
|
242
Immunome
IMNM
$916M
| $13.5M | 0.11% |
924,392
+1,500
| +0.2% | +$21.9K |
|
|
MBX
243
MBX Biosciences, Inc. Common Stock
MBX
$388M
| $13.5M | 0.11% |
+519,675
| New | +$13.5M |
|
244
Vishay Intertechnology
VSH
$2.11B
| $13.5M | 0.11% |
712,618
-935,326
| -57% | -$17.7M |
|
245
American Financial Group
AFG
$11.6B
| $13.4M | 0.11% |
99,841
+10,995
| +12% | +$1.48M |
|
246
Lyft
LYFT
$6.91B
| $13.4M | 0.11% |
+1,051,054
| New | +$13.4M |
|
247
Bilibili
BILI
$9.25B
| $13.4M | 0.11% |
571,899
+186,022
| +48% | +$4.35M |
|
248
Amneal Pharmaceuticals
AMRX
$3.02B
| $13.3M | 0.11% |
1,604,531
+289,508
| +22% | +$2.41M |
|
249
Warrior Met Coal
HCC
$3.19B
| $13.2M | 0.11% |
+206,803
| New | +$13.2M |
|
|
WBTN
250
WEBTOON Entertainment Inc. Common Stock
WBTN
$1.88B
| $13.1M | 0.11% |
1,140,800
+1,600
| +0.1% | +$18.3K |
|